Skip to main content
Signal8

Asep Medical Holdings Inc. (SEPSF)

Sector: In Vitro & In Vivo Diagnostic Substances

Industry: Biotechnology

Asep Medical Holdings Inc logo

Asep Medical Holdings Inc

OTC:SEPSFHealthcare
Mkt Cap-
EV-
Float6.58M
O/S10.86M
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 12, 20260.01090.01090.01090.010920
Nov 9, 20260.01090.01090.01090.010920
Nov 6, 20260.01090.01090.01090.010920
Nov 3, 20260.01090.01090.01090.010920
Nov 2, 20260.01090.01090.01090.010920
Oct 30, 20260.01090.01090.01090.010920
Oct 29, 20260.01090.01090.01090.010920
Oct 26, 20260.01090.01090.01090.010920
Oct 23, 20260.01090.01090.01090.010920
Oct 20, 20260.01090.01090.01090.010920
Oct 19, 20260.01090.01090.01090.010920
Oct 16, 20260.01090.01090.01090.010920
Oct 15, 20260.01090.01090.01090.010920
Oct 12, 20260.01090.01090.01090.010920
Oct 9, 20260.01090.01090.01090.010920
Oct 6, 20260.01090.01090.01090.010920
Oct 5, 20260.01090.01090.01090.010920
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
About

Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions.

The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc.

Its corporate base of operations is located in Vancouver, Canada.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding10.86M
Authorized Shares
Float6.58M
52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

--

90d Avg

--

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...